Infective endocarditis in adults

New England Journal of Medicine

Volumn 345, Issue 18, 2001, Pages 1318-1330

  Mylonakis, Eleftherios ^a   Calderwood, Stephen B ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; METICILLIN; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DISEASE PREDISPOSITION; ENDOCARDITIS; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; REVIEW; SPLEEN ABSCESS; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTI-INFECTIVE AGENTS; BACTEREMIA; CENTRAL NERVOUS SYSTEM DISEASES; COMBINED MODALITY THERAPY; ECHOCARDIOGRAPHY; ENDOCARDITIS; ENDOCARDITIS, BACTERIAL; HEART FAILURE, CONGESTIVE; HEART VALVE PROSTHESIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 0035522333     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra010082     Document Type: Review

References (99)

1. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
2. Incidence of infective endocarditis in the Delaware Valley, 1988-1990
3. Epidemiologic aspects of infective endocarditis in an urban population: A 5-year prospective study
4. Infective endocarditis at a large community teaching hospital, 1980-1990: A review of 210 episodes
5. Right-side endocarditis in injection drug users: Review of proposed mechanisms of pathogenesis
6. Risk factors for infective endocarditis: Oral hygiene and nondental exposures
7. Human immunodeficiency virus infection and infective endocarditis among injecting drug users
8. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users
9. Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease)
10. Natural history of mitral valve prolapse
11. Clinical spectrum of infective endocarditis: 15 Years experience
12. Active infective endocarditis observed in an Indian hospital 1981-1991
13. Incidence and risk factors of prosthetic valve endocarditis
14. Risk factors for the development of prosthetic valve endocarditis
15. Prosthetic valve endocarditis
16. The prevalence of infective endocarditis after aortic valve replacement
17. Infective endocarditis: Ten-year review of medical and surgical therapy
18. Prosthetic valve endocarditis: Analysis of factors affecting outcome of therapy
19. Hospital-acquired infective endocarditis not associated with cardiac surgery: An emerging problem
20. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: A 20-year experience
21. An analysis of 110 serious enterococcal infections: Epidemiology, antibiotic susceptibility, and outcome
22. Endocarditis due to rare and fastidious bacteria
23. Infective endocarditis in patients with negative blood cultures: Analysis of 88 cases from a one-year nationwide survey in France
24. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing
25. Diagnosis of 22 new cases of Bartonella endocarditis
26. Whipple endocarditis without overt gastrointestinal disease: Report of four cases
27. Diagnosis and management of infective endocarditis and its complications
28. Bartonella (Rochalimaea) quintana endocarditis in three homeless men
29. Bartonella (Rochalimaea) species as a cause of an apparent "culture-negative" endocarditis
30. Cultivation of the bacillus of Whipple's disease
31. Nosocomial endocarditis in the intensive care unit: An analysis of 22 cases
32. Prosthetic valve endocarditis resulting from nosocomial bacteremia: A prospective, multicenter study
33. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia
34. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography
35. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: A prospective study
36. Cardiac conduction abnormalities complicating native valve active infective endocarditis
37. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings
38. Evaluation of new clinical criteria for the diagnosis of infective endocarditis
39. Native valve infective endocarditis in elderly and younger adult patients: Comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database
40. An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis
41. An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis
42. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis
43. Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis: Could sensitivity be improved?
44. Negative predictive value of the Duke criteria for infective endocarditis
45. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
46. Determinants of the occurrence of and survival from prosthetic valve endocarditis: Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease
47. Long-term complications of native valve infective endocarditis in non-addicts: A 15-year follow-up study
48. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis
49. Infective endocarditis in the elderly in the era of transesophageal echocardiography: Clinical features and prognosis compared with younger patients
50. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions
51. Echocardiography in patients with suspected endocarditis: A cost-effective analysis
52. Clinical impact of transesophageal echocardiography in the diagnosis and management of infective endocarditis
53. ACC/AHA guidelines for the clinical application ofechocardiography: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography): Developed in collaboration with the American Society of Echocardiography
54. Diagnostic value of echocardiography in suspected endocarditis: An evaluation based on the pretest probability of disease
55. Endocarditis-associated paravalvular abscesses: Do clinical parameters predict the presence of abscess?
56. Annular abscesses in surgical endocarditis: Anatomic, clinical, and operative features
57. Perivalvular abscesses associated with endocarditis: Clinical features and prognostic factors of overall survival in a series of 233 cases: Perivalvular Abscesses French Multicentre Study
58. Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: Correlation with anatomic findings
59. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients
60. Clinical features of Staphylococcus aureus endocarditis: A 10-year experience in Denmark
61. Neurologic manifestations in Staphylococcus aureus endocarditis: A review of 260 bacteremic cases in nondrug addicts
62. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia
63. Infective endocarditis due to Staphylococcus aureus: 59 Prospectively identified cases with follow-up
64. Surgical management of infective endocarditis associated with cerebral complications: Multi-center retrospective study in Japan
65. Neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland
66. Emboli in infective endocarditis: The prognostic value of echocardiography
67. Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis
68. Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: Importance of aneurysm size
69. Splenic septic emboli in endocarditis
70. Persistent fever in association with infective endocarditis
71. Antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis
72. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms
73. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study
74. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptoccci
75. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: Two-week combination therapy
76. Right-sided endocarditis in intravenous drug users: Prognostic features in 102 episodes
77. Influence of vegetation size on clinical outcome of right-sided infective endocarditis
78. Treatment of Q fever endocarditis: Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine
79. Q fever 1985-1998: Clinical and epidemiologic features of 1,383 infections
80. Infective endocarditis due to Staphylococcus aureus: Deleterious effect of anticoagulant therapy
81. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects
82. Aortic insufficiency in bacterial endocarditis
83. Heart failure in infective endocarditis: Predisposing factors, course, and treatment
84. Analysis of surgical versus medical therapy in active complicated native valve infective endocarditis
85. Treatment of infective endocarditis: A 10-year comparative analysis
86. Surgery for active culture-positive endocarditis: Determinants of early and late outcome
87. Surgical treatment of infective mitral valve endocarditis: Predictors of early and late outcome
88. Timing of surgery in patients with acute infective endocarditis
89. Practice guidelines for the treatment of candidiasis
90. Fungal endocarditis: Evidence in the world literature, 1965-1995
91. Active native valve endocarditis: Determinants of operative death and late mortality
92. Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death
93. Natural history of vegetations during successful medical treatment of endocarditis
94. Valve replacement in patients with endocarditis and cerebral septic emboli
95. Does a focal neurologic deficit contraindicate operation in a patient with endocarditis?
96. Hemorrhagic and ischemic cerebrovascular complications of active infective endocarditis of native valve
97. Valve replacement in patients with endocarditis and acute neurologic deficit
98. Are blood and valve cultures predictive for long-term outcome following surgery for infective endocarditis?